EDIT-401
Asset
In vivo gene editing to lower LDL cholesterol levels
- Stage
- Phase 1
- Modality
- Gene editing
- Target
- Lipid and ceramide metabolism
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Hyperlipidemia
Phase 1, globenewswire.com, 8 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Evidence for its targets1
- Competitors12
Every asset’s record: target, stage, trials and the evidence behind it.